Correction: Prospective evaluation of efficacy, safety, cumulative laser energy, and stone-free rates in the post-market SOLTIVE™ superpulsed laser system registry: insights from team of worldwide endourological researchers’ (T.O.W.E.R.) research consortium

Résumé fourni par la source

SFRs), ablative performance, and patient outcomes following ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), or mini-PCNL with the first commercially available TFL system, SOLTIVE™ SuperPulsed Laser System (Gyrus ACMI, Inc. doing business as Olympus Surgical Technologies America).but should have read as This prospective study conducted by the investigators of the Team of Worldwide Endourological Researchers' (T.O.W.E.R.) research consortium on behalf of the Endourological Society aimed to evaluate the stone-free rates (SFRs), ablative performance, and patient outcomes Correction: Urolithiasis (2025) 53:56 h t t p s : / / d o i . o r g / 1 0 . 1 0 0 7 / s 0 0 2 4 0 -0 2 5 -0 1 7 2 0 -5In the original version of this article, "mini-PCNL and PCNL patients" were mistakenly added in the introduction section.The last sentence of the introduction section, which previously read as This prospective study conducted by the investigators of the Team of Worldwide Endourological Researchers' (T.O.W.E.R.) research consortium on behalf of the Endourological Society aimed to evaluate the stone-free ratesThe original article can be found online at h t t p s : / / d o i . o r g / 1 0 . 1 0 0 7 / s 0 0 2 4 0 -0 2 5 -0 1 7 2 0 -5.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.